Follow-up of patients affected by manganese-induced Parkinsonism after treatment with CaNa2EDTA.

[1]  K. Lyons,et al.  Effect of levodopa treatment for parkinsonism in welders , 2004, Neurology.

[2]  C. Yoo,et al.  Whole blood manganese correlates with high signal intensities on T1-weighted MRI in patients with liver cirrhosis. , 2003, Neurotoxicology.

[3]  E. Pira,et al.  Manganese intoxication: the cause of an inexplicable epileptic syndrome in a 3 year old child. , 2003, Neurotoxicology.

[4]  Barry S. Levy,et al.  Neurologic Effects of Manganese in Humans: A Review , 2003, International journal of occupational and environmental health.

[5]  K. Hsu,et al.  Environmental lead exposure and progression of chronic renal diseases in patients without diabetes. , 2003, The New England journal of medicine.

[6]  M. Valentini,et al.  T1-weighted hyperintensity in basal ganglia at brain magnetic resonance imaging: are different pathologies sharing a common mechanism? , 2002, Neurotoxicology.

[7]  K. Ono,et al.  Myoclonic involuntary movement associated with chronic manganese poisoning , 2002, Journal of the Neurological Sciences.

[8]  J. Mink,et al.  Welding-related parkinsonism , 2001, Neurology.

[9]  E. Pira,et al.  Occupational Mn parkinsonism: magnetic resonance imaging and clinical patterns following CaNa2-EDTA chelation. , 2000, Neurotoxicology.

[10]  L Alessio,et al.  Brain magnetic resonance imaging and manganese exposure. , 2000, Neurotoxicology.

[11]  J. W. Kim,et al.  Increase in signal intensities on T1-weighted magnetic resonance images in asymptomatic manganese-exposed workers. , 1999, Neurotoxicology.

[12]  M. Buchem.  Magnetization transfer: applications in neuroradiology. , 1999 .

[13]  K. Murata,et al.  Behavior of heavy metals in human urine and blood following calcium disodium ethylenediamine tetraacetate injection: observations in metal workers. , 1998, Journal of toxicology and environmental health. Part A.

[14]  D. Krieger,et al.  Manganese and chronic hepatic encephalopathy , 1995, The Lancet.

[15]  S. Caroldi,et al.  In Vivo Inhibition of Serum Dopamine-β-Hydroxylase by CaNa2 EDTA injection , 1994 .

[16]  P. Xie,et al.  A report of two cases of chronic serious manganese poisoning treated with sodium para-aminosalicylic acid. , 1992, British journal of industrial medicine.

[17]  V. Batuman,et al.  The safety of the EDTA lead-mobilization test. , 1983, Environmental research.

[18]  S. Khandelwal,et al.  Chelation in metal intoxication XII , 1982, Archives of Toxicology.

[19]  S. Folstein,et al.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. , 1975, Journal of psychiatric research.

[20]  Wynter Je.  The prevention of manganese poisoning. , 1962 .

[21]  L. Goodman,et al.  THE PHARMACOLOGICAL BASIS OF THERAPEUTICS , 1966 .

[22]  J. Nachtman,et al.  Manganese neurotoxicity: effects of varying oxygen tension and EDTA on dopamine auto-oxidation. , 1987, Neurotoxicology.

[23]  C. Marsden,et al.  Recent Developments in Parkinson's Disease , 1986 .

[24]  S Fahn,et al.  Chronic manganese intoxication. , 1974, Archives of neurology.

[25]  Kosal Mf,et al.  Ethylenediaminetetraacetic acid in manganese poisoning of rats; a preliminary study. , 1956 .

[26]  R. Peñalver.  Manganese Poisoning. The 1954, Ramazzini Oration. , 1955 .